Wasazra Pharmaceuticals Limited
About Wasazra Pharmaceuticals Limited
Data last updated:
Wasazra Pharmaceuticals Limited is a public limited company based in Lucknow, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 01 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2017PLC093735. Its GSTIN is 09AACCW0173F1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sayed Ahmad Masood Hashmi (Managing Director) and Azra Waseem.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.46 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹12.62 Lakh (net margin 2%) and EBITDA of ₹18.96 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address628C/30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wasazra Pharmaceuticals Limited
The main business activity of Wasazra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wasazra Pharmaceuticals Limited FY 2025 filings available
Wasazra Pharmaceuticals Limited reported revenue of ₹6.46 Cr (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Wasazra Pharmaceuticals Limited
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wasazra Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.96 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.62 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wasazra Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wasazra Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sayed Ahmad Masood Hashmi | Managing Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Azra Waseem | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Nida Fatima | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Firdaus Fatima Also directs: Integral Startups Foundation, Ze&H Textiles Private Limited | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
Peer Comparison of Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Viskaan Pharma Pvt Ltd | ₹6.48 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Telangana, India |
| Bravo Pharmaceuticals Private Limited | ₹6.47 Cr (FY 2024) | •••• | •••• | 750.0% | •••• | New Delhi, Delhi, India |
| Carexiaa Healthcare Private Limited | ₹6.47 Cr (FY 2024) | •••• | •••• | 42.0% | •••• | Badlapur, Maharashtra, India |
| Lotus Pharmacy Private Limited | ₹6.47 Cr (FY 2025) | •••• | •••• | 939.0% | •••• | Chennai, Tamil Nadu, India |
| Ckris Laboratories Private Limited | ₹6.47 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Navi Mumbai, Maharashtra, India |
| Wasazra Pharmaceuticals Limited this company | ₹6.46 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Lucknow, Uttar Pradesh, India |
| Rheo Pharma Private Limited | ₹6.46 Cr (FY 2024) | •••• | •••• | 525.0% | •••• | Hyderabad, Telangana, India |
| Helpline Pharmacy Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Vira Lifesciences Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Lucknow, Uttar Pradesh, India |
| Raxem Bio Tech Private Limited | ₹6.45 Cr (FY 2023) | •••• | •••• | 26.0% | •••• | Coimbatore, Tamil Nadu, India |
| Tejaswi Biotech Private Limited | ₹6.43 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Wasazra Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Wasazra Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wasazra Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Wasazra Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals Limited has 6 board changes on record since 2017: 5 appointments and 1 cessation. The latest: Syed Mohammad Fauzan Akhtar ceased to be Managing Director on 14 May 2024.
Credit Ratings, Litigation & Regulatory Alerts for Wasazra Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wasazra Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wasazra Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW0173F1ZG | Uttar Pradesh | Active | 21 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wasazra Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wasazra Pharmaceuticals Limited
Wasazra Pharmaceuticals is an active public limited company based in Lucknow, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 01 June 2017 (9+ years old) and is registered under CIN U51909UP2017PLC093735.
Wasazra Pharmaceuticals reported revenue of ₹6.46 Cr for FY 2024 (down 2% YoY).
Wasazra Pharmaceuticals has 4 current directors:
- Sayed Ahmad Masood Hashmi - Managing Director
- Azra Waseem - Director
- Nida Fatima - Director
- Firdaus Fatima - Director
Wasazra Pharmaceuticals reported a net profit of ₹12.62 Lakh (net margin 2%) and EBITDA of ₹18.96 Lakh (EBITDA margin 2.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wasazra Pharmaceuticals is 56% over three years and 26% over five years. In the latest year (FY 2024) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wasazra Pharmaceuticals is 09AACCW0173F1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Wasazra Pharmaceuticals is U51909UP2017PLC093735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wasazra Pharmaceuticals was incorporated on 01 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Wasazra Pharmaceuticals by revenue are Viskaan Pharma Pvt Ltd, Bravo Pharmaceuticals Private Limited, Carexiaa Healthcare Private Limited, Lotus Pharmacy Private Limited, Ckris Laboratories Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Syed Mohammad Fauzan Akhtar ceased to be Managing Director on 14 May 2024. Syed Mohammad Fauzan Akhtar was appointed as Managing Director on 28 Jun 2017. Azra Waseem was appointed as Director on 01 Jun 2017. Wasazra Pharmaceuticals has 6 board changes on record in total.
The registered office of Wasazra Pharmaceuticals is at 628C30 Sarvodai Nagar, Lucknow, Uttar Pradesh, India – 226016.